Disease-Modifying Drugs Extend Survival in Hereditary Transthyretin Amyloid Polyneuropathy.

Ueda, Mitsuharu; Misumi, Yohei; Nomura, Toshiya; Tasaki, Masayoshi; Yamakawa, Shiori; Obayashi, Konen; Yamashita, Taro; Ando, Yukio

Ueda, Mitsuharu; Misumi, Yohei; Nomura, Toshiya; Tasaki, Masayoshi; Yamakawa, Shiori; Obayashi, Konen; Yamashita, Taro; Ando, Yukio.

Afiliação

Ueda M; Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Misumi Y; Amyloidosis Center, Kumamoto University Hospital, Kumamoto, Japan.
Nomura T; Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Tasaki M; Amyloidosis Center, Kumamoto University Hospital, Kumamoto, Japan.
Yamakawa S; Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Obayashi K; Amyloidosis Center, Kumamoto University Hospital, Kumamoto, Japan.
Yamashita T; Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Ando Y; Amyloidosis Center, Kumamoto University Hospital, Kumamoto, Japan.

Ann Neurol ; 95(2): 230-236, 2024 Feb.

Article em En | MEDLINE | ID: mdl-38053464

Assuntos

Neuropatias Amiloides Familiares; Neuropatias Amiloides; Polineuropatias; Humanos; Neuropatias Amiloides Familiares/tratamento farmacológico; Neuropatias Amiloides Familiares/genética; Pré-Albumina/genética; Estudos Retrospectivos; Neuropatias Amiloides/tratamento farmacológico; Neuropatias Amiloides/genética; Amiloide

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polineuropatias / Neuropatias Amiloides / Neuropatias Amiloides Familiares Limite: Humans Idioma: En Revista: Ann Neurol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google